Takeda Posts ¥517.00 Non-GAAP EPS, ¥4505.7B Revenue for FY, Issues FY2026 Outlook
Takeda Pharmaceutical reports a 1.7% year-over-year revenue decline but maintains strong cash flow and forecasts FY2026 targets. Takeda Pharmaceutical reported a non-GAAP EPS of ¥517.00 and revenue of ¥4505.7 billion for the fiscal year, marking a 1.7% decline year-over-ye